Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1 | Q15116 | 6/20 | 0.49 |
| ▸ | CD274 | Q9NZQ7 | 6/20 | 0.49 |
| ▸ | MRGPRX4 | Q96LA9 | 6/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | KDM4A | O75164 | 1/20 | 0.39 |
| ▸ | KDM5A | P29375 | 1/20 | 0.39 |
| ▸ | KMO | O15229 | 2/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.38 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5079669 | 0.92 | PDCD1 (0.49) | PDCD1CD274MRGPRX4TP53HTT | |
| SCHEMBL5075838 | 0.87 | MRGPRX4 (0.44) | PDCD1CD274MRGPRX4TP53HTT | |
| SCHEMBL6148645 | 0.85 | PDCD1 (0.47) | PDCD1CD274MRGPRX4TP53HTT | |
| SCHEMBL6148647 | 0.82 | PDCD1 (0.45) | PDCD1CD274MRGPRX4TP53HTT | |
| SCHEMBL6148643 | 0.82 | PDCD1 (0.45) | PDCD1CD274MRGPRX4TP53HTT | |
| SCHEMBL6150443 | 0.82 | PDCD1 (0.49) | PDCD1CD274MRGPRX4TP53HTT | |
| SCHEMBL6150439 | 0.82 | PDCD1 (0.49) | PDCD1CD274MRGPRX4TP53HTT | |
| SCHEMBL5075864 | 0.82 | PDCD1 (0.49) | PDCD1CD274MRGPRX4TP53HTT | |
| SCHEMBL5075839 | 0.79 | MRGPRX4 (0.43) | PDCD1CD274MRGPRX4TP53HTT | |
| SCHEMBL5075861 | 0.78 | HIF1A (0.55) | PDCD1CD274MRGPRX4TP53HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7435844-B2 | Analogous compounds of strobilurines and their use as acaricides and insecticides | ISAGRO RICERCA S.R.L. (IT) | 2008-10-14 | — | — | US | disclosed |
| US-20060235075-A1 | Analogous compounds of strobilurines and their use as acaricides and insecticides | ISAGRO RICERCA S.R.L. (IT) | 2006-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060235075-A1 | Analogous compounds of strobilurines and their use as acaricides and insecticides | DDT, RYR1, TPMT | PDCD1 1930/4885CD274 1960/4885MRGPRX4 989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.